Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999

被引:87
作者
Livermore, DM
James, D
Reacher, M
Graham, C
Nichols, T
Stephens, P
Johnson, AP
George, RC
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
[2] Ctr Communicable Dis Surveillance, London, England
[3] IMS Hlth UK, Pinner, Middx, England
关键词
D O I
10.3201/eid0805.010204
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Public Health Laboratory Service receives antibiotic susceptibility data for bacteria from bloodstream infections from most hospitals in England and Wales. These data were used to ascertain resistance trends to ciprofloxacin from 1990 through 1999 for the most prevalent gram-negative agents: Escherichia coli, Klebsiella spp., Enterobacter spp., and Proteus mirabilis. Significant increases in resistance were observed for all four species groups. For E. coli, ciprofloxacin resistance rose from 0.8% in 1990 to 3.7% in 1999 and became widely scattered among reporting hospitals. The prevalence of resistance in Klebsiella spp. rose from 3.5% in 1990, to 9.5% in 1996 and 7.1% in 1999, while that in Enterobacter spp. rose from 2.1% in 1990 to 10.5% in 1996 and 10.9% in 1999. For both Klebsiella and Enterobacter spp., most resistance was localized in a few centers. Resistance was infrequent and scattered in R mirabilis, but reached a prevalence of 3.3% in 1999.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 19 条
[1]   INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].
BAUERNFEIND, A ;
PETERMULLER, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115
[2]   AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].
COX, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3
[3]   Multiresistant bacteria as a hospital epidemic problem [J].
Dennesen, PJW ;
Bonten, MJM ;
Weinstein, RA .
ANNALS OF MEDICINE, 1998, 30 (02) :176-185
[4]   Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J].
Everett, MJ ;
Jin, YF ;
Ricci, V ;
Piddock, LJV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2380-2386
[5]   Emergence and dissemination of quinolone-resistant Escherichia coli in the community [J].
Garau, J ;
Xercavins, M ;
Rodríguez-Carballeira, M ;
Gómez-Vera, JR ;
Coll, I ;
Vidal, D ;
Llovet, T ;
Ruíz-Bremón, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2736-2741
[6]   EMERGENCE OF FLUOROQUINOLONE-RESISTANT ESCHERICHIA-COLI AT A CANCER CENTER [J].
KERN, WV ;
ANDRIOF, E ;
OETHINGER, M ;
KERN, P ;
HACKER, J ;
MARRE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :681-687
[7]   Are routine sensitivity test data suitable for the surveillance of resistance?: Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing [J].
Livermore, DM ;
Threlfall, EJ ;
Reacher, MH ;
Johnson, AP ;
James, D ;
Cheasty, T ;
Shah, A ;
Warburton, F ;
Swan, AV ;
Graham, A ;
Speller, DCE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (02) :205-211
[8]   Quinolone resistance from a transferable plasmid [J].
Martínez-Martínez, L ;
Pascual, A ;
Jacoby, GA .
LANCET, 1998, 351 (9105) :797-799
[9]  
Maschmeyer G, 1993, Drugs, V45 Suppl 3, P73
[10]  
Nema S, 1997, Indian J Med Sci, V51, P275